Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

734 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal cancer to investigate the Impact of Learning Effect).
Matsuoka H, Ogata Y, Nakamura M, Shibata Y, Munemoto Y, Bando H, Nishijima K, Okuda H, Terada I, Shiroiwa T, Kishimoto J, Maeda K. Matsuoka H, et al. Among authors: bando h. J Anus Rectum Colon. 2020 Apr 28;4(2):79-84. doi: 10.23922/jarc.2019-020. eCollection 2020. J Anus Rectum Colon. 2020. PMID: 32346646 Free PMC article.
Multicenter study of short- and long-term outcomes of laparoscopic palliative resection for incurable, symptomatic stage IV colorectal cancer in Japan.
Akagi T, Inomata M, Kitano S, Hida K, Sakai Y, Hasegawa S, Kinjo Y, Yoshimura K, Ito M, Fukunaga Y, Kanazawa A, Idani H, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery. Akagi T, et al. J Gastrointest Surg. 2013 Apr;17(4):776-83. doi: 10.1007/s11605-013-2173-x. Epub 2013 Feb 22. J Gastrointest Surg. 2013. PMID: 23435696
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).
Matsuda C, Honda M, Tanaka C, Fukunaga M, Ishibashi K, Munemoto Y, Hata T, Bando H, Oshiro M, Kobayashi M, Tokunaga Y, Fujii A, Nagata N, Oba K, Mishima H. Matsuda C, et al. Among authors: bando h. Int J Clin Oncol. 2016 Jun;21(3):566-72. doi: 10.1007/s10147-015-0911-7. Epub 2015 Oct 16. Int J Clin Oncol. 2016. PMID: 26475356 Clinical Trial.
Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer.
Kotaka M, Yamanaka T, Yoshino T, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Nakamura F, Bando H, Taniguchi H, Gamoh M, Shiozawa M, Saji S, Maehara Y, Mizushima T, Ohtsu A, Mori M. Kotaka M, et al. Among authors: bando h. ESMO Open. 2018 Apr 24;3(3):e000354. doi: 10.1136/esmoopen-2018-000354. eCollection 2018. ESMO Open. 2018. PMID: 29713499 Free PMC article.
Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial.
Yoshino T, Yamanaka T, Oki E, Kotaka M, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Takeuchi S, Bando H, Taniguchi H, Gamoh M, Shiozawa M, Mizushima T, Saji S, Maehara Y, Ohtsu A, Mori M. Yoshino T, et al. Among authors: bando h. JAMA Oncol. 2019 Nov 1;5(11):1574-1581. doi: 10.1001/jamaoncol.2019.2572. JAMA Oncol. 2019. PMID: 31513248 Free PMC article. Clinical Trial.
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial.
Yoshino T, Oki E, Misumi T, Kotaka M, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Nakamura F, Bando H, Taniguchi H, Sakamoto Y, Shiozawa M, Nishi M, Horiuchi T, Yamagishi H, Sakamoto J, Mizushima T, Ohtsu A, Mori M. Yoshino T, et al. Among authors: bando h. J Clin Oncol. 2022 Oct 10;40(29):3419-3429. doi: 10.1200/JCO.21.02628. Epub 2022 May 5. J Clin Oncol. 2022. PMID: 35512259 Clinical Trial.
Impact of the endoscopic surgical skill qualification system on conversion to laparotomy after low anterior resection for rectal cancer in Japan (a secondary analysis of the EnSSURE study).
Goto K, Watanabe J, Nagasaki T, Uemura M, Ozawa H, Kurose Y, Akagi T, Ichikawa N, Iijima H, Inomata M, Taketomi A, Naitoh T; EnSSURE study group collaboratives in Japan Society of Laparoscopic Colorectal Surgery. Goto K, et al. Surg Endosc. 2024 May;38(5):2454-2464. doi: 10.1007/s00464-024-10740-y. Epub 2024 Mar 8. Surg Endosc. 2024. PMID: 38459211 Free PMC article.
Usefulness of participation of endoscopic surgical skill qualification system-qualified surgeons in laparoscopic high anterior resection.
Sawada N, Mukai S, Akagi T, Okamoto K, Fujita F, Suwa H, Ide Y, Furuhata T, Kanazawa A, Shimamura T, Kojima S, Ohnuma S, Kinjo T, Ichikawa N, Yamaguchi S, Taketomi A, Naitoh T; EnSSURE Study Group Collaboratives in the Japan Society of Laparoscopic Colorectal Surgery. Sawada N, et al. Asian J Endosc Surg. 2025 Jan-Dec;18(1):e13409. doi: 10.1111/ases.13409. Asian J Endosc Surg. 2025. PMID: 39575540
734 results